Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2018-08-01
2020-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dietary fiber 1
Participants receive cereal flakes 1 to include it in their normal diet.
Dietary intervention
Dietary intervention: Participants receive dietary fibers for a defined number of days.
Dietary fiber 2
Participants receive cereal flakes 2 to include it in their normal diet.
Dietary intervention
Dietary intervention: Participants receive dietary fibers for a defined number of days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary intervention
Dietary intervention: Participants receive dietary fibers for a defined number of days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* daily alcohol consumption \<20g (men) or \<10g (women)
Exclusion Criteria
* instable body weight
* BMI \<18,5 kg/m2 or \>25 kg/m2
* bariatric surgery within the last 5 years
* intake of antibiotics within the last month or during the study
* daily alcohol consumption \>20g (men) or \>10g (women)
* pregnancy and/or lactation period
* viral or bacterial infection during the last three weeks
* increased inflammatory markers of unknown reason
* chronic or acute disease of gastrointestinal tract
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Ina Bergheim
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Vienna
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UVienna19
Identifier Type: -
Identifier Source: org_study_id